New bladder cancer drug offers hope for avoiding bladder removal
NCT ID NCT07468851
First seen Mar 17, 2026 · Last updated May 19, 2026 · Updated 6 times
Summary
This study tests a new drug called HS-10566 in people with high-risk bladder cancer that hasn't spread into the muscle wall. It is for those who cannot have or choose not to have their bladder removed. The study has two parts: first finding the best dose, then checking how well it works at controlling the cancer. About 180 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Drum Tower Hospital
Nanjing, 210008, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University First Hospital
Beijing, 100034, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.